| 摘要 |
The use of an IP3 receptor-mediated calcium channel blocker for treating a variety of diseases is herein described. Specifically, the IP3 receptor-mediated calcium channel blocker prevents activation of the transcription factor NF-kB. As a consequence, the IP3 receptor-mediated calcium channel blocker is used as a treatment for diseases and disorders requiring NF-kB activation, for example, inflammatory diseases, some viral infections and some unregulated growth disorders. |
